6605 Merrill Creek Parkway
66 articles with Altasciences
Altasciences announced today the appointment of Dr. Joseph A. Francisco as Chief Toxicologist, effective June 22, 2020.
Altasciences announced today the appointment of Dr. Gaetano Morelli as Chief Medical Officer, effective May 14, 2020. Dr. Morelli is a member of the College of Physicians of Québec, Canada, with over 30 years' medical experience and over 20 years' global clinical research background. He joined Altasciences in 2013 as a GI consultant and then signed on with Altasciences in 2017, first as Medical Advisor, then Clinical PI, and now Chief Medic
Altasciences has completed a Phase I study for the development of gimsilumab, a fully human monoclonal antibody that targets granulocyte-macrophage colony stimulating factor (GM-CSF), found to be up-regulated in SARS CoV-2 in patients with or at risk of developing acute respiratory distress syndrome (ARDS).
Altasciences , a CRO in the U.S. and Canada specializing in a flexible, innovative approach to comprehensive early stage drug development, announced today that they have entered into an agreement with Amador Bioscience , a translational and consulting clinical research organization located in China and the U.S. This partnership aims to expand world-class capabilities and resources to promote drug development in China and North America.
Altasciences announced the addition of Paul Sidney to their Compliance and Regulatory Affairs team as Senior Director
Martin will apply his extensive knowledge and experience to guide internal and external clients throughout their bioanalysis and immunomodulation analysis projects.
Dr. Gorman became a diplomate of the American College of Laboratory Animal Medicine in 2018.
Altasciences is pleased to announce the addition of Dr. Lynne LeSauteur, PhD, to their bioanalytical management team, responsible for the Bioanalytical Services department in the U.S.A. and the Ligand Binding team in Canada.
8/9/2019Biopharma companies strengthen their senior leadership teams and boards of directors.
Beatrice has a Ph.D. in Pharmacology and Neuroscience from the University of Toronto and since 2005 has been involved in clinical trials in Canada and the U.S.A.
Altasciences Leads Research on Chemical Nerve Agent Therapeutic from Preclinical to Clinical Phase I
Altasciences will conduct the required Safety Testing, all IND-enabling studies (non-GLP and GLP), the necessary Phase I clinical trials, and associated bioanalytical analysis.
WuXi Clinical, the clinical CRO arm of WuXi AppTec, will be responsible for managing the partnership and ensuring a seamless experience.
For the 2019 CRO Leadership Awards, Life Science Leader magazine once again teamed up with Industry Standard Research to determine the award recipients.
Altasciences announced today that it has signed a definitive agreement to acquire the preclinical testing business of SNBL U.S.A.
PPD, Inc. And SNBL Complete Joint Venture To Provide Japanese Clinical Development Services And Additional Collaborations
PPD, Inc. And SNBL Announce Japanese Clinical Development Joint Venture And Additional Collaborations
G2B Pharma Receives Project Financing From Sosei Group Corporation And Right To In-License Nasal Delivery Technologies From SNBL